Dr. Ammar Sukari
Claim this profileWayne State University/Karmanos Cancer Institute
Expert in Squamous Cell Carcinoma
Expert in Cancer
27 reported clinical trials
44 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Global LeaderStage IV
Stage III
PD-L1 positive
2Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Ammar Sukari is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies
Recruiting1 award Phase 1 & 2
Trastuzumab Emtansine
for Salivary Gland Cancer
This phase II trial tests whether ado-trastuzumab emtansine works to shrink tumors in patients with HER2-positive salivary gland cancer that has come back (recurrent), spread to other places in the body (metastatic), or cannot be removed by surgery (unresectable). Trastuzumab emtansine is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called emtansine. Trastuzumab attaches to HER2 positive cancer cells in a targeted way and delivers emtansine to kill them. Trastuzumab emtansine may work better compared to usual treatment of chemotherapy with docetaxel and trastuzumab in treating patients with salivary gland cancer.
Recruiting1 award Phase 2
More about Ammar Sukari
Clinical Trial Related1 year of experience running clinical trials · Led 27 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Ammar Sukari has experience with
- Cisplatin
- Pembrolizumab
- Nivolumab
- Intensity-Modulated Radiation Therapy
- Carboplatin
- Image Guided Radiation Therapy
Breakdown of trials Ammar Sukari has run
Squamous Cell Carcinoma
Cancer
Oropharyngeal Carcinoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ammar Sukari specialize in?
Ammar Sukari focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Ammar Sukari currently recruiting for clinical trials?
Yes, Ammar Sukari is currently recruiting for 14 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Ammar Sukari has studied deeply?
Yes, Ammar Sukari has studied treatments such as Cisplatin, Pembrolizumab, Nivolumab.
What is the best way to schedule an appointment with Ammar Sukari?
Apply for one of the trials that Ammar Sukari is conducting.
What is the office address of Ammar Sukari?
The office of Ammar Sukari is located at: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan 48201 United States. This is the address for their practice at the Wayne State University/Karmanos Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.